Arimoclomol
Small Molecule
Overview
Arimoclomol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2107726).
Patent & exclusivity (US)
Per the FDA Orange Book (4 approved US products), the latest listed US patent on Arimoclomol expires 19 Nov 2041 and exclusivity 20 Sept 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (3Z)-N-[(2R)-2-hydroxy-3-piperidin-1-ylpropoxy]-1-oxidopyridin-1-ium-3-carboximidoyl chloride
- Canonical SMILES
- C1CCN(CC1)C[C@H](CO/N=C(/C2=C[N+](=CC=C2)[O-])\Cl)O
- InChIKey
- SGEIEGAXKLMUIZ-XUVDNFPMSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.